None" title="" class="btn" data-container="body" data-html="true" data-id="99539" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="DeepLife"> 44 3,316
Activities
Technologies
Entity types
Location
75013 Paris, France
Paris
France
Employees
Scale: 11-50
Estimated: 27
Engaged corporates
21Added in Motherbase
4 years agoAI for digital twin of cells
DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells.
While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases.
The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior.
We are working closely with biotech and pharmaceutical companies to accelerate their target identification processes. We are also collaborating actively with the academic community by publishing papers and providing open access to our platform’s features and data.
Drug Discovery, Pharmaceutical, Deep Learning, and Biotech
AI for digital twin of cells
DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells.
While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases.
The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior.
We are working closely with biotech and pharmaceutical companies to accelerate their target identification processes. We are also collaborating actively with the academic community by publishing papers and providing open access to our platform’s features and data.
At DeepLife, we harness deep learning on multi-omics data to model cells and efficiently engineer their behavior
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() UCB Pharmaceutical Manufacturing | UCB Pharmaceutical Manufacturing | Other 11 Mar 2025 | | |
![]() Capgemini Consulting, IT Services and IT Consulting | Capgemini Consulting, IT Services and IT Consulting | Other 11 Mar 2025 | | |
![]() numeum IT Services and IT Consulting | numeum IT Services and IT Consulting | Other 13 Feb 2025 | | |
![]() Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 13 Feb 2025 | | |
![]() Future4Care Startup accelerator & VC | Future4Care Startup accelerator & VC | Other 17 Mar 2025 | | |
![]() | Rise Partners | Other 16 Dec 2024 | | |
![]() Sifted Newspaper Publishing | Sifted Newspaper Publishing | Other 11 Dec 2024 | | |
![]() Beiersdorf Cosmetics, Chemistry, Personal Care Product Manufacturing | Beiersdorf Cosmetics, Chemistry, Personal Care Product Manufacturing | Other 11 Dec 2024 | | |
![]() Entrepreneur First Startup accelerator & VC, Venture Capital and Private Equity Principals | Entrepreneur First Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 18 Dec 2024 | | |
![]() STATION F Startup accelerator & VC, Software Development | STATION F Startup accelerator & VC, Software Development | Other 13 Feb 2025 | |